How have the Australian Banks performed since the GFC?

Australian banks have been hit hard by the Hayne royal commission. But how have they performed over the longer term?

Considering the performance of America’s biggest bank, JPMorgan Chase. Chief executive Jamie Dimon is the longest-serving chief executive on Wall Street. He led the bank through the financial crisis when its share price fell to just under US$23 in January 2009, four months after the collapse of Lehman Brothers. This week, under Dimon’s leadership, JPMorgan Chase shares hit at a record high of US$120. The bank has a market cap of $381 billion. Take a look at how these six Australian banks have performed since the global financial crisis (GFC):

1. Macquarie: up 653 per cent Macquarie shares have grown significantly since hitting a low of $19 in late February 2009. Today they are trading at around $128, a 653 per cent increase in just over a decade. Allan Moss handed over the CEO reins to Nicholas Moore in May 2008. Mr Moore led the business through the financial crisis and delivered a $2.6 billion profit for the group before retiring in November last year. He was CEO for over a decade.

2. CBA: up 182 per cent Unlike JPMorgan Chase, some Aussie banks have had multiple leadership changes since the GFC. The nation’s biggest bank, CBA, was led by Ralph Norris during the financial crisis, when its shares were trading at $29 in early January 2009. Since then the group’s share price has risen 182 per cent to $82.

3. ANZ: up 125 per cent The smallest of the big four banks by market capitalisation, ANZ was led by Mike Smith during the financial crisis, when its share price hit a low of $12 in January 2009. Shayne Elliott took over as CEO in 2015, becoming the first internally appointed CEO in 30 years. The bank’s share price has more than doubled since the GFC to around $27 today.

4. Westpac: up 100 per cent Gail Kelly took over as Westpac CEO in February 2008 and led the bank through the financial crisis. Its share price dropped to $14.5 in January 2009 and has doubled in 10 years to around $29 today. The bank has been led by CEO Brian Hartzer since February 2015.

5. NAB: up 81 per cent NAB was singled out in the royal commission final report for its poor oversight and leadership, particularly in relation to fees or no service. Today, NAB shares are trading at $29 under the leadership of new CEO Ross McEwan, an 81 per cent increase in March 2009.

6. AMP: down 52 per cent AMP shares plummeted to $3.82 in early March 2009 from a record high of $10.84 a year earlier. But today they are trading at a record low of $1.83. New CEO Francesco De Ferrari is confident he can turn the business around, investing over $500 billion in the group’s wealth business over the next three years with a focus on digital advice.

Article Sourced from click https://www.nestegg.com.au/earn-money/how-have-bank-stocksperformed-since-the-gfc? utm_source=Nestegg&utm_campaign=20_09_19&utm_medium=email&utm_content=1

The Benchmarking Group our latest member

The Benchmarking Group was formed in 2006 and has 3 distinct areas of business:

1) www.bmkit.com.au or Benchmarking Hosting & IT is a generalist IT provider with focus on data security for cloud enabled SMEs

2) www.bmkvoip.com.au or Benchmarking PBX & VoIP is a B2B cloud phone system provider and telco

3) last but not least - www.benchmarking.com.au or Benchmarking Data & Research is a SaaS application providing benchmarking data and technology to accounting firms and business advisories in Australia and New Zealand. Established in 1989 as part of UNE in Armidale, Benchmarking.com.au and its predecessor FMRC have delivered business insights to Australian businesses across 100+ industries for decades.

A new Member to SwissCham to serve all Members from the D-A-CH Region

German Australian Marketing Services is a dedicated Marketing Consulting and Marketing Outsourcing Service for DACH and Australian businesses, bridging the gap to allow a competitive advantage in your unique market.

Our local marketing expertise and familiarity with relevant consumer behaviour ensures that we can connect DACH businesses with Australian markets, and vice versa.

It’s our goal to see your business thrive. With us, you will receive prompt communication, ongoing support, and unparalleled marketing knowledge regarding your particular trade.

German Australian Marketing Services is wholeheartedly focused on the development of your business, considering an array of marketing options to enhance your growth in the DACH and Australian markets: Marketing Communications, Online Marketing, Media Planning, Market Research, Market Analysis, Benchmark Analysis, Marketing Strategy, Customer Satisfaction Surveys, NPS, Translation Services for Businesses and Individuals.

Marketing Consultant & Marketing Outsourcing PartnerGerman Australian Marketing ServicesMobile: +61 490 101 118 Web: gamarketing.com.au Mail: katrin@gamarketing.com.au

CMRI - Childrens Research Institute

download.png

Not all research is the same

CMRI conducts fundamental (meaning fundamentally important) medical and biological research. We ask the difficult questions. What causes cancer? How do we stop it? Why does development go wrong and how can we prevent it? How does the brain work? Can what we’ve learned be put to use to treat cancer, epilepsy and genetic diseases?

Our task is to make the future better

CMRI scientists ask the difficult questions in order to gain the important answers. This knowledge enables us to light the spark of discovery and to create a healthier future for all children.

What we’ve accomplished in the last 20 years:

  • World-first project to revolutionise cancer diagnosis and personalise treatment planning within 7 years, part of the 'Moonshot' to end cancer

  • Found a single genetic defect can cause cleft lip and palate

  • Fate map of the early embryo to help us understand many developmental problems

  • Identification of the components of telomerase, which will be important for treating 85% of all cancers

  • Discovery of the Alternative Lengthening of Telomeres (ALT) mechanism, which can lead to treatments for the other 15% of cancers

  • Developing a blood test for ALT cancers that will allow physicians to diagnose and plan treatments for cancers such as aggressive glioblastoma brain tumours

  • Partnering with the Children’s Hospital Westmead on a cure for genetic liver disease, with clinical trials about to begin

  • Discovering and developing a new class of drugs for treating epilepsy

What we plan to accomplish in the next 20 years:

  • Develop epilepsy treatments that will help children (and adults) around the world

  • Develop new treatments for kidney disease and diabetes

  • Provide more gene therapy cures for rare genetic diseases in children

  • New treatments for infectious diseases

  • Telomere research to help us understand predisposition to disease

  • Find new and better treatments for every type of cancer